OpGen (OPGN) Competitors $1.99 +0.03 (+1.53%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends OPGN vs. ENZ, BNR, MRAI, CCM, PMD, BRTX, TOI, OTRK, ATIP, and MGRXShould you be buying OpGen stock or one of its competitors? The main competitors of OpGen include Enzo Biochem (ENZ), Burning Rock Biotech (BNR), Marpai (MRAI), Concord Medical Services (CCM), Psychemedics (PMD), BioRestorative Therapies (BRTX), Oncology Institute (TOI), Ontrak (OTRK), ATI Physical Therapy (ATIP), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry. OpGen vs. Enzo Biochem Burning Rock Biotech Marpai Concord Medical Services Psychemedics BioRestorative Therapies Oncology Institute Ontrak ATI Physical Therapy Mangoceuticals OpGen (NASDAQ:OPGN) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation. Do institutionals & insiders believe in OPGN or ENZ? 2.7% of OpGen shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 43.8% of OpGen shares are owned by company insiders. Comparatively, 15.5% of Enzo Biochem shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer OPGN or ENZ? In the previous week, OpGen and OpGen both had 1 articles in the media. OpGen's average media sentiment score of 0.00 equaled Enzo Biochem'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OpGen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Enzo Biochem 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation and earnings, OPGN or ENZ? Enzo Biochem has higher revenue and earnings than OpGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOpGen$3.42M4.86-$32.67MN/AN/AEnzo Biochem$31.91M1.62-$26.08MN/AN/A Which has more volatility & risk, OPGN or ENZ? OpGen has a beta of -0.59, meaning that its share price is 159% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500. Is OPGN or ENZ more profitable? Enzo Biochem has a net margin of -81.73% compared to OpGen's net margin of -1,140.36%. OpGen's return on equity of 0.00% beat Enzo Biochem's return on equity.Company Net Margins Return on Equity Return on Assets OpGen-1,140.36% N/A -287.58% Enzo Biochem -81.73%-11.84%-8.31% Does the MarketBeat Community favor OPGN or ENZ? OpGen received 89 more outperform votes than Enzo Biochem when rated by MarketBeat users. However, 55.35% of users gave Enzo Biochem an outperform vote while only 53.94% of users gave OpGen an outperform vote. CompanyUnderperformOutperformOpGenOutperform Votes30153.94% Underperform Votes25746.06% Enzo BiochemOutperform Votes21255.35% Underperform Votes17144.65% SummaryEnzo Biochem beats OpGen on 7 of the 11 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get OpGen News Delivered to You Automatically Sign up to receive the latest news and ratings for OPGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPGN vs. The Competition Export to ExcelMetricOpGenMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.64M$3.06B$5.07B$8.90BDividend YieldN/A11.18%4.99%4.07%P/E RatioN/A9.1287.8613.46Price / Sales4.86215.451,228.8287.66Price / CashN/A406.7839.5136.27Price / Book5.533.216.946.30Net Income-$32.67M-$32.86M$119.12M$225.93M7 Day Performance5.85%0.56%-1.84%-1.32%1 Month Performance13.71%-0.22%-3.65%0.60%1 Year Performance-51.46%26.01%31.64%26.23% OpGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPGNOpGenN/A$1.99+1.5%N/A-55.8%$16.64M$3.42M0.00100News CoverageENZEnzo Biochem0.5158 of 5 stars$0.99-2.0%N/A-22.3%$51.57M$31.91M0.00520BNRBurning Rock BiotechN/A$4.64+0.9%N/A-48.5%$47.51M$75.70M0.001,390MRAIMarpai2.0113 of 5 stars$1.64+13.1%$6.00+265.9%+80.2%$22.53M$37.15M-0.62150CCMConcord Medical Services0.3453 of 5 stars$4.35-3.3%N/A-58.6%$18.88M$75.69M0.00970Gap UpPMDPsychemedics0.5329 of 5 stars$2.33-0.4%N/A+11.0%$13.72M$22.10M-4.57140BRTXBioRestorative Therapies3.7191 of 5 stars$1.49+6.4%$18.00+1,108.1%-22.2%$10.31M$150,000.00-0.927Analyst RevisionNews CoverageGap UpTOIOncology Institute2.3174 of 5 stars$0.14+2.9%$2.50+1,738.2%-94.1%$10.27M$324.24M0.00660Gap DownOTRKOntrak2.7304 of 5 stars$1.72-6.0%$45.00+2,516.3%-79.4%$7.26M$12.74M0.00250Gap DownATIPATI Physical Therapy0.224 of 5 stars$1.59-7.6%N/A-78.2%$7.01M$699.02M0.005,600MGRXMangoceuticals0.508 of 5 stars$2.49+0.8%N/A-98.1%$6.20M$730,000.000.003 Related Companies and Tools Related Companies ENZ Competitors BNR Competitors MRAI Competitors CCM Competitors PMD Competitors BRTX Competitors TOI Competitors OTRK Competitors ATIP Competitors MGRX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OPGN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OpGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OpGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
